MAP-ENDEarly Neurovascular Decoupling Trajectories in Acute Ischemic Stroke Patients After Revascularization
This observational study aims to examine the changes in a composite neurovascular decoupling index from Day 1 to Day 7 after revascularization in acute ischemic stroke patients, using Transcranial Doppler, Electroencephalography, and F-wave persistence measurements.
Data Collection
Collected from today forward - ProspectiveIschemic Stroke+5
+ Brain Diseases
+ Cardiovascular Diseases
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: February 5, 2026
Actual date on which the first participant was enrolled.This study focuses on understanding the recovery process after a successful revascularization treatment for acute ischemic stroke, a condition caused by blockages in blood vessels leading to the brain. Despite successful treatment, patients often experience varying levels of functional recovery, which is not well understood. The study aims to explore the changes in the brain's blood flow and neural activity connection, known as neurovascular coupling, in the early days after treatment. It is believed that these changes may impact the patient's long-term recovery. The study will observe adult patients who have undergone successful endovascular thrombectomy within 24 hours of stroke symptoms. During the study, participants will undergo multimodal monitoring, which includes Transcranial Doppler (TCD), Electroencephalography (EEG), and F-wave studies. These tests measure cerebral hemodynamic status, cortical neuroelectrical activity, and spinal anterior horn motoneuron excitability, respectively. The study will track these measurements at different time points: within 24-72 hours post-thrombectomy, at Day 7, and at Day 90. The goal is to identify patterns in these measurements that can predict a patient's functional outcome 90 days after the stroke.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.180 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 85 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives